Dermatitis News

Vitamin D supplementation was effective in treating winter-related atopic dermatitis in Mongolian children who were at high risk for vitamin D deficiency when compared with placebo in a recent study.

In honor of the first International Urticaria Day, Novartis Pharmaceuticals Canada announced the launch of its Skin Impressions campaign, designed to give insight into the lives of people with chronic idiopathic urticaria.

Sanofi and Regeneron Pharmaceuticals announced that a phase 2a study of dupilumab met all endpoints in patients with chronic sinusitis with nasal polyps who did not respond to intranasal corticosteroids, according to a press release.

Researchers found that although children with chronic urticaria typically have positive outcomes, there is no one factor that can significantly predict remission.

Water-damaged homes were significantly associated with children with moderate to severe atopic dermatitis, according to recent study results.

AbbVie announced positive results from its phase 3 study of Humira for the treatment of hidradenitis suppurativa at the 44th Annual European Society for Dermatological Research Meeting, according to a company press release.

Filaggrin loss-of-function mutations were more strongly associated with food allergy risk in children aged 10 and 18 than in younger children, according to recent study results.

One course of intravenous immunoglobulins was insufficient for prolonged remission in patients with solar urticaria, according to recent study results.

Despite no identified predictor of remission, children with chronic urticaria had a 67.7% remission rate at 5 years after onset of symptoms, according to recent study results.

A significant association between increased BMI from childhood to adolescence and higher incidence of atopic or respiratory diseases could not be established in recent study results.